FLIP-2 Study-Reference-Cited by-同舟云学术

FLIP-2 Study

Published:2008-09 Issue:9 Volume:27 Page:788-793
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Figueras-Aloy José,Carbonell-Estrany Xavier,Quero-Jiménez José,Fernández-Colomer Belén,Guzmán-Cabañas Juana,Echaniz-Urcelay Iñaqui,Doménech-Martínez Eduardo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33–35 weeks in Spain.;Figueras-Aloy;Pediatr Infect Dis J,2004

2. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study.;Carbonell-Estrany;Pediatr Infect Dis J,2000

3. Hospitalization rates for respiratory syncytial virus (RSV) infection in premature infants born during two consecutive seasons.;Carbonell-Estrany;Pediatr Infect Dis J,2001

4. Nomenclature et classification des problemes liés à la consommation de drogue et alcohol; mémorandum OMS.;Edwards;Bull Organ Mondiale Santé,1982

5. Two-sided confidence intervals for the single proportion: comparison of seven methods.;Newcombe;Statis Med,1998

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal Risk Factors for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Otherwise Healthy Preterm and Term Infants: A Systematic Review and Meta-analysis;Pediatric Infectious Disease Journal;2024-05-15

2. Risk Factors of Long PICU Stay for Term-Born Bronchiolitis Patients Less than 3 Years Old;Cyprus Journal of Medical Sciences;2024-04-01

3. A Retrospective Public Health Assessment and Management in Terms of the Social and Clinical Risk Factors of Respiratory Syncytial Virus Infection in Northern Canada;Cureus;2024-02-01

4. Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants;Frontiers in Pediatrics;2024-01-12

5. Respiratory syncytial virus and metapneumovirus;Molecular Medical Microbiology;2024